Annual CFO
-$350.57 M
-$126.17 M-56.23%
31 December 2023
Summary:
Revolution Medicines annual cash flow from operations is currently -$350.57 million, with the most recent change of -$126.17 million (-56.23%) on 31 December 2023. During the last 3 years, it has fallen by -$203.39 million (-138.19%). RVMD annual CFO is now -29001.24% below its all-time high of $1.21 million, reached on 31 December 2018.RVMD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$130.42 M
-$2.25 M-1.76%
30 September 2024
Summary:
Revolution Medicines quarterly cash flow from operations is currently -$130.42 million, with the most recent change of -$2.25 million (-1.76%) on 30 September 2024. Over the past year, it has dropped by -$9.86 million (-8.17%). RVMD quarterly CFO is now -1033.88% below its all-time high of -$11.50 million, reached on 30 June 2019.RVMD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$539.71 M
-$29.92 M-5.87%
30 September 2024
Summary:
Revolution Medicines TTM cash flow from operations is currently -$539.71 million, with the most recent change of -$29.92 million (-5.87%) on 30 September 2024. Over the past year, it has dropped by -$189.14 million (-53.95%). RVMD TTM CFO is now -4181.71% below its all-time high of -$12.61 million, reached on 31 March 2019.RVMD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVMD Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -8.2% | -54.0% |
| 3 y3 years | -138.2% | -232.2% | -266.7% |
| 5 y5 years | -606.6% | -1019.3% | -987.8% |
RVMD Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -138.2% | at low | -232.2% | +18.8% | -266.7% | at low |
| 5 y | 5 years | -606.6% | at low | -1019.3% | +18.8% | -987.8% | at low |
| alltime | all time | <-9999.0% | at low | -1033.9% | +18.8% | -4181.7% | at low |
Revolution Medicines Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$130.42 M(+1.8%) | -$539.71 M(+5.9%) |
| June 2024 | - | -$128.17 M(-20.2%) | -$509.79 M(+13.6%) |
| Mar 2024 | - | -$160.56 M(+33.2%) | -$448.74 M(+28.0%) |
| Dec 2023 | -$350.57 M(+56.2%) | -$120.56 M(+20.0%) | -$350.57 M(+20.1%) |
| Sept 2023 | - | -$100.50 M(+49.7%) | -$291.80 M(+20.1%) |
| June 2023 | - | -$67.12 M(+7.6%) | -$243.04 M(+4.9%) |
| Mar 2023 | - | -$62.39 M(+1.0%) | -$231.63 M(+3.2%) |
| Dec 2022 | -$224.40 M(+52.5%) | -$61.79 M(+19.4%) | -$224.40 M(+11.2%) |
| Sept 2022 | - | -$51.74 M(-7.1%) | -$201.88 M(+8.1%) |
| June 2022 | - | -$55.72 M(+1.0%) | -$186.73 M(+13.1%) |
| Mar 2022 | - | -$55.16 M(+40.5%) | -$165.09 M(+12.2%) |
| Dec 2021 | -$147.18 M | -$39.27 M(+7.3%) | -$147.18 M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$36.59 M(+7.4%) | -$132.95 M(+7.8%) |
| June 2021 | - | -$34.08 M(-8.5%) | -$123.38 M(+12.9%) |
| Mar 2021 | - | -$37.25 M(+48.8%) | -$109.29 M(+9.2%) |
| Dec 2020 | -$100.06 M(+101.7%) | -$25.03 M(-7.4%) | -$100.06 M(+15.4%) |
| Sept 2020 | - | -$27.02 M(+35.2%) | -$86.68 M(+17.9%) |
| June 2020 | - | -$19.99 M(-28.6%) | -$73.52 M(+13.1%) |
| Mar 2020 | - | -$28.02 M(+140.5%) | -$65.03 M(+31.1%) |
| Dec 2019 | -$49.62 M(-4190.4%) | -$11.65 M(-15.9%) | -$49.62 M(+30.7%) |
| Sept 2019 | - | -$13.86 M(+20.5%) | -$37.96 M(+57.5%) |
| June 2019 | - | -$11.50 M(-8.8%) | -$24.11 M(+91.2%) |
| Mar 2019 | - | -$12.61 M | -$12.61 M |
| Dec 2018 | $1.21 M(-104.8%) | - | - |
| Dec 2017 | -$25.15 M | - | - |
FAQ
- What is Revolution Medicines annual cash flow from operations?
- What is the all time high annual CFO for Revolution Medicines?
- What is Revolution Medicines quarterly cash flow from operations?
- What is the all time high quarterly CFO for Revolution Medicines?
- What is Revolution Medicines quarterly CFO year-on-year change?
- What is Revolution Medicines TTM cash flow from operations?
- What is the all time high TTM CFO for Revolution Medicines?
- What is Revolution Medicines TTM CFO year-on-year change?
What is Revolution Medicines annual cash flow from operations?
The current annual CFO of RVMD is -$350.57 M
What is the all time high annual CFO for Revolution Medicines?
Revolution Medicines all-time high annual cash flow from operations is $1.21 M
What is Revolution Medicines quarterly cash flow from operations?
The current quarterly CFO of RVMD is -$130.42 M
What is the all time high quarterly CFO for Revolution Medicines?
Revolution Medicines all-time high quarterly cash flow from operations is -$11.50 M
What is Revolution Medicines quarterly CFO year-on-year change?
Over the past year, RVMD quarterly cash flow from operations has changed by -$9.86 M (-8.17%)
What is Revolution Medicines TTM cash flow from operations?
The current TTM CFO of RVMD is -$539.71 M
What is the all time high TTM CFO for Revolution Medicines?
Revolution Medicines all-time high TTM cash flow from operations is -$12.61 M
What is Revolution Medicines TTM CFO year-on-year change?
Over the past year, RVMD TTM cash flow from operations has changed by -$189.14 M (-53.95%)